Top Story

PCORI opens comment period on peer review, release of research findings draft

September 18, 2014

The Patient-Centered Outcomes Research Institute approved its draft proposal process for peer review and public release of primary research findings and has opened a public comment period that will close on Friday, Nov. 7.

“Our proposed peer review process and open science framework aim to advance the transparency and quality of useful new evidence,” Joe Selby, MD, MPH, PCORI executive director, said in a press release. “We expect to benefit greatly from input during the public comment period for the draft peer review proposal and we look forward to issuing the final process.”

In the Journals

Vitamin E, selenium have scant effect on cataract in men

September 18, 2014
Daily selenium and/or vitamin E supplementation is unlikely to have a significant impact on the onset and progression of age-related cataract in men, according to…
Meeting News Coverage

Addition of chemotherapy to radiation failed to improve outcomes in esophageal cancer

September 18, 2014
The addition of chemotherapy to radiation therapy increased gastrointestinal toxicity but did not confer significant improvement in dysphagia or survival among patients…

Patent filed for injectable HBV, liver cancer drug in China

September 18, 2014
Biostar Pharmaceuticals has filed an invention and creation patent application in China for oleanolic acid injection for the treatment of hepatitis B virus infection and…
More News Headlines »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
figure

Researchers identify link between neoadjuvant chemotherapy response, locoregional recurrence risk

September 17, 2014
Julia White, MD, director of breast radiation oncology and vice chair of clinical research at The Ohio State University…
More »
CME
figure

Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

This activity is supported by an educational grant from Genentech, Inc.

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, but the numerous subtypes make this disease…
More »